InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Dockendorff Charles J, 董事. Insider active across 5 companies, notably Boston Scientific CORP. Aggregated, 29 filings have been published. Breakdown: 1 buy · 3 sells. Total volume traded: €1.9m. Activity tracked since 6 May 2021. The latest transaction was disclosed on 20 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Dockendorff Charles J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报29 总计
15,370 股Common StockSEC:0000859737-26-000061:1
6,626 股Common StockSEC:0000859737-26-000061:0
870 股0Common StockSEC:0001400563-26-000002:0
3,190 股Common StockSEC:0000859737-26-000017:0
2,693 股Common StockSEC:0001127602-25-019594:0
1,589 股0Common StockSEC:0001601046-25-000033:0
1,864 股Common StockSEC:0001127602-25-007230:0
2,207 股Common StockSEC:0001127602-24-021037:0
2,901 股0Common StockSEC:0001225208-24-005966:0
3,946 股@ US$72.7025.1% 占其流量Common StockSEC:0001225208-24-005800:0
1,632 股0Common StockSEC:0001601046-24-000026:0
1,572 股Common StockSEC:0001127602-24-009476:0
7,551 股@ US$38.44100.0% 占其流量Common StockSEC:0001127602-24-000817:0
10,215 股@ US$87.68100.0% 占其流量Common StockSEC:0001127602-23-023851:0
17,079 股@ US$50.742574.9% 占其流量Common StockSEC:0001225208-23-008340:0
2,226 股Common StockSEC:0001127602-23-022207:0
3,946 股0Common StockSEC:0001225208-23-005466:0
1,543 股0Common StockSEC:0001601046-23-000035:0
1,465 股Common StockSEC:0001127602-23-009866:0
1,336 股0Common StockSEC:0001127602-23-004222:0
2,844 股0Common StockSEC:0001601046-23-000002:0
7,551 股0Common StockSEC:0001601046-22-000158:0
2,730 股Common StockSEC:0001127602-22-020699:0
4,877 股0Common StockSEC:0001225208-22-006716:0
1,626 股0Common StockSEC:0001601046-22-000030:0
29 条申报中的 25 条
About Dockendorff Charles J
Dockendorff Charles J is an Administrateur at HOLOGIC INC, Keysight Technologies, Inc., Boston Scientific CORP and HAEMONETICS CORP. Across 29 total filings, the most recent filings we hold cover the period from 2016-02-16 to 2026-04-09, with EUR 0 of buys and EUR 1898791 of sells, and the modal transaction nature is Attribution.
